
Incyte
company0.0Global Dominance: 0.00%
Incyte is a biopharmaceutical company known for its focus on oncology and other serious diseases, developing novel therapeutics to improve patient outcomes. Established in 1991, Incyte has made significant contributions to cancer treatment, particularly with its FDA-approved drugs. The company has a notable production facility in Yverdon, Switzerland, which enhances its capabilities to supply the U.S. market amidst changing trade dynamics.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Incyte has a notable production site in Yverdon, Switzerland.
US-Zölle auf Medikamente: Schweiz drohen ProduktionsverlagerungenNeue Zürcher Zeitung·
Switzerland· 2025-03-22







